ResMed Property Plant Equipment vs Short Long Term Debt Analysis
RMD Stock | USD 218.06 34.64 18.89% |
ResMed financial indicator trend analysis is much more than just breaking down ResMed Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ResMed Inc is a good investment. Please check the relationship between ResMed Property Plant Equipment and its Short Long Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Property Plant Equipment vs Short Long Term Debt
Property Plant Equipment vs Short Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ResMed Inc Property Plant Equipment account and Short Long Term Debt. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between ResMed's Property Plant Equipment and Short Long Term Debt is -0.38. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Short Long Term Debt in the same time period over historical financial statements of ResMed Inc, assuming nothing else is changed. The correlation between historical values of ResMed's Property Plant Equipment and Short Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of ResMed Inc are associated (or correlated) with its Short Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt has no effect on the direction of Property Plant Equipment i.e., ResMed's Property Plant Equipment and Short Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.38 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Property Plant Equipment
Short Long Term Debt
The total of a company’s short-term and long-term borrowings.Most indicators from ResMed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ResMed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At present, ResMed's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 451 M, whereas Issuance Of Capital Stock is forecasted to decline to about 48.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.0B | 2.4B | 2.7B | 2.8B | Total Revenue | 3.6B | 4.2B | 4.9B | 5.1B |
ResMed fundamental ratios Correlations
Click cells to compare fundamentals
ResMed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ResMed fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.6B | 4.7B | 5.1B | 6.8B | 7.8B | 8.2B | |
Short Long Term Debt Total | 1.3B | 793.7M | 917.6M | 1.6B | 1.8B | 1.9B | |
Other Current Liab | 335.1M | 628.6M | 389.6M | 437.9M | 503.6M | 528.7M | |
Total Current Liabilities | 602.8M | 911.8M | 689.3M | 758.5M | 872.3M | 915.9M | |
Total Stockholder Equity | 2.5B | 2.9B | 3.4B | 4.1B | 4.7B | 5.0B | |
Property Plant And Equipment Net | 535.7M | 592.1M | 630.5M | 665.8M | 765.7M | 804.0M | |
Net Debt | 836.1M | 498.4M | 643.8M | 1.4B | 1.6B | 1.6B | |
Retained Earnings | 2.8B | 3.1B | 3.6B | 4.3B | 4.9B | 5.1B | |
Accounts Payable | 135.8M | 138.0M | 159.2M | 150.8M | 173.4M | 182.0M | |
Cash | 463.2M | 295.3M | 273.7M | 227.9M | 262.1M | 335.8M | |
Non Current Assets Total | 3.1B | 3.2B | 3.2B | 4.4B | 5.0B | 5.3B | |
Non Currrent Assets Other | 189.7M | 240.8M | 251.5M | 395.4M | 454.7M | 477.5M | |
Cash And Short Term Investments | 463.2M | 295.3M | 273.7M | 227.9M | 262.1M | 340.4M | |
Net Receivables | 474.6M | 614.3M | 576.0M | 704.9M | 810.6M | 851.2M | |
Common Stock Shares Outstanding | 145.7M | 146.5M | 147.0M | 147.5M | 169.6M | 147.3M | |
Liabilities And Stockholders Equity | 4.6B | 4.7B | 5.1B | 6.8B | 7.8B | 8.2B | |
Non Current Liabilities Total | 1.5B | 930.7M | 1.0B | 1.9B | 2.1B | 2.2B | |
Inventory | 416.9M | 457.0M | 743.9M | 998.0M | 1.1B | 1.2B | |
Other Current Assets | 168.7M | 208.2M | 337.9M | 437.0M | 502.6M | 527.7M | |
Other Stockholder Equity | (52.6M) | (1.1M) | 59.2M | 148.8M | 133.9M | 140.6M | |
Total Liab | 2.1B | 1.8B | 1.7B | 2.6B | 3.0B | 3.2B | |
Total Current Assets | 1.5B | 1.6B | 1.9B | 2.4B | 2.7B | 2.9B | |
Short Term Debt | 33.3M | 35.6M | 31.8M | 31.8M | 36.6M | 66.7M | |
Intangible Assets | 448.2M | 392.6M | 345.9M | 552.3M | 635.2M | 667.0M | |
Property Plant And Equipment Gross | 535.7M | 592.1M | 630.5M | 665.8M | 765.7M | 804.0M | |
Accumulated Other Comprehensive Income | (284.0M) | (193.5M) | (312.7M) | (272.5M) | (245.3M) | (233.0M) | |
Common Stock Total Equity | 571K | 575K | 580K | 583K | 670.5K | 417.0K | |
Common Stock | 580K | 583K | 586K | 588K | 676.2K | 435.6K | |
Other Assets | 145.6M | 240.8M | 202.3M | 261.3M | 300.5M | 315.5M | |
Good Will | 1.9B | 1.9B | 1.9B | 2.8B | 3.2B | 3.3B | |
Property Plant Equipment | 535.7M | 592.1M | 630.5M | 665.8M | 765.7M | 384.1M | |
Other Liab | 221.6M | 172.6M | 160.0M | 315.2M | 362.5M | 380.6M | |
Long Term Debt | 1.2B | 643.4M | 765.3M | 1.4B | 1.6B | 1.7B | |
Current Deferred Revenue | 98.6M | 109.6M | 108.7M | 138.1M | 158.8M | 166.7M | |
Net Tangible Assets | 158.5M | 565.2M | 1.1B | 807.3M | 726.5M | 632.7M | |
Long Term Debt Total | 1.3B | 1.2B | 643.4M | 765.3M | 880.1M | 737.7M | |
Capital Surpluse | 1.5B | 1.6B | 1.6B | 1.7B | 1.9B | 1.5B |
Currently Active Assets on Macroaxis
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Transaction History View history of all your transactions and understand their impact on performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.291 | Dividend Share 1.88 | Earnings Share 6.04 | Revenue Per Share 31.175 | Quarterly Revenue Growth 0.072 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.